Literature DB >> 8245795

Disseminated tuberculosis in interferon gamma gene-disrupted mice.

A M Cooper1, D K Dalton, T A Stewart, J P Griffin, D G Russell, I M Orme.   

Abstract

The expression of protective immunity to Mycobacterium tuberculosis in mice is mediated by T lymphocytes that secrete cytokines. These molecules then mediate a variety of roles, including the activation of parasitized host macrophages, and the recruitment of other mononuclear phagocytes to the site of the infection in order to initiate granuloma formation. Among these cytokines, interferon gamma (IFN-gamma) is believed to play a key role is these events. In confirmation of this hypothesis, we show in this study that mice in which the IFN-gamma gene has been disrupted were unable to contain or control a normally sublethal dose of M. tuberculosis, delivered either intravenously or aerogenically. In such mice, a progressive and widespread tissue destruction and necrosis, associated with very high numbers of acid-fast bacilli, was observed. In contrast, despite the lack of protective immunity, some DTH-like reactivity could still be elicited. These data, therefore, indicate that although IFN-gamma may not be needed for DTH expression, it plays a pivotal and essential role in protective cellular immunity to tuberculosis infection.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8245795      PMCID: PMC2191280          DOI: 10.1084/jem.178.6.2243

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  18 in total

1.  T lymphocytes mediating protection and cellular cytolysis during the course of Mycobacterium tuberculosis infection. Evidence for different kinetics and recognition of a wide spectrum of protein antigens.

Authors:  I M Orme; E S Miller; A D Roberts; S K Furney; J P Griffin; K M Dobos; D Chi; B Rivoire; P J Brennan
Journal:  J Immunol       Date:  1992-01-01       Impact factor: 5.422

2.  The kinetics of emergence and loss of mediator T lymphocytes acquired in response to infection with Mycobacterium tuberculosis.

Authors:  I M Orme
Journal:  J Immunol       Date:  1987-01-01       Impact factor: 5.422

3.  Capacity of human neutrophils to kill Mycobacterium tuberculosis.

Authors:  A E Brown; T J Holzer; B R Andersen
Journal:  J Infect Dis       Date:  1987-12       Impact factor: 5.226

4.  Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction.

Authors:  J R David
Journal:  Proc Natl Acad Sci U S A       Date:  1966-07       Impact factor: 11.205

5.  Tumour necrosis factor alpha restores granulomas and induces parasite egg-laying in schistosome-infected SCID mice.

Authors:  P Amiri; R M Locksley; T G Parslow; M Sadick; E Rector; D Ritter; J H McKerrow
Journal:  Nature       Date:  1992-04-16       Impact factor: 49.962

6.  Multiple defects of immune cell function in mice with disrupted interferon-gamma genes.

Authors:  D K Dalton; S Pitts-Meek; S Keshav; I S Figari; A Bradley; T A Stewart
Journal:  Science       Date:  1993-03-19       Impact factor: 47.728

7.  Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection.

Authors:  J L Flynn; M M Goldstein; K J Triebold; B Koller; B R Bloom
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

Review 8.  T cell response to Mycobacterium tuberculosis.

Authors:  I M Orme; P Andersen; W H Boom
Journal:  J Infect Dis       Date:  1993-06       Impact factor: 5.226

9.  Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity.

Authors:  C F Nathan; H W Murray; M E Wiebe; B Y Rubin
Journal:  J Exp Med       Date:  1983-09-01       Impact factor: 14.307

10.  An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection.

Authors:  J L Flynn; J Chan; K J Triebold; D K Dalton; T A Stewart; B R Bloom
Journal:  J Exp Med       Date:  1993-12-01       Impact factor: 14.307

View more
  781 in total

1.  Tumor necrosis factor (TNF) and a TNF-mimetic peptide modulate the granulomatous response to Mycobacterium bovis BCG infection in vivo.

Authors:  D R Roach; H Briscoe; K Baumgart; D A Rathjen; W J Britton
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

Review 2.  Partners in crime: co-infections in the developing world.

Authors:  A Pennycook; P Openshaw; T Hussell
Journal:  Clin Exp Immunol       Date:  2000-12       Impact factor: 4.330

3.  A cooperative oxygen-binding hemoglobin from Mycobacterium tuberculosis.

Authors:  M Couture; S R Yeh; B A Wittenberg; J B Wittenberg; Y Ouellet; D L Rousseau; M Guertin
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

4.  Role of eosinophils in the pathogenesis of Mycobacterium bovis BCG infection in gamma interferon receptor-deficient mice.

Authors:  J Kirman; Z Zakaria; K McCoy; B Delahunt; G Le Gros
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

Review 5.  The cells that knew too much.

Authors:  A G Baxter
Journal:  J Clin Invest       Date:  2000-06       Impact factor: 14.808

6.  Reactivation of tuberculosis is associated with a shift from type 1 to type 2 cytokines.

Authors:  A D Howard; B S Zwilling
Journal:  Clin Exp Immunol       Date:  1999-03       Impact factor: 4.330

7.  HLA-B*35-restricted CD8(+)-T-cell epitope in Mycobacterium tuberculosis Rv2903c.

Authors:  Michèl R Klein; Abdulrahman S Hammond; Steve M Smith; Assan Jaye; Pauline T Lukey; Keith P W J McAdam
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

Review 8.  Cytokines in innate host defense in the lung.

Authors:  Robert M Strieter; John A Belperio; Michael P Keane
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

Review 9.  Tuberculosis: latency and reactivation.

Authors:  J L Flynn; J Chan
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

10.  Search for new drugs for treatment of tuberculosis.

Authors:  I Orme
Journal:  Antimicrob Agents Chemother       Date:  2001-07       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.